In the development process for medical devices, there comes a point when products transfer from design to production.
Often this step doesn’t go as smoothly as it should and the project budget and schedule are adversely impacted. Companies may view design transfer as a one-time event, rather than an essential part of an ongoing process.
During the product development process, the Research and Development (R&D) team is under a tight deadline. They may not have the necessary resources or take sufficient time to create proper documentation. Team members may need to make decisions quickly without fully considering how they could take proactive steps to ensure design transfer will go more smoothly. Subject matter experts on the team may only focus on critical design decisions required to make the product work, without regard for manufacturing. Let’s take a look at some ways to improve design transfer.
Design transfer is an integral part of the product development process, from conception through final manufacture. Highly reliable, cost-efficient medical devices require proper design transfer, and that starts with Design for Manufacturability (DFM) and Design for Manufacturing and Assembly (DFMA). In DFM and DFMA the focus is not only on the design itself, but also on the assembly method, ensuring manufacturing readiness for building Beta units, pre-production clinical units, and the pilot program. When the R&D team considers these factors and performs in-process testing, it can significantly improve product quality and reduce the overall cost of manufacturing.
The goal of DFMA is simple: to transfer product design into viable, robust production methods. To succeed, the team must establish and maintain procedures that ensure the device design translates into production specifications, including final test acceptance. The transfer should negate and/or identify remaining risks such as single-sourcing, long lead items, build timelines, and line/tooling capacity.
At Sunrise Labs, we see Design Transfer as an integral process beginning early in the life of a product with many crucial steps for success. Communication between key stakeholders early and often is critical to turn innovative ideas into commercial medical devices.
Why is design transfer a critical step in medical device development?
Common mistakes companies make during design transfer:
How to improve design transfer success:
What are the goals of DFMA?
Characteristics of a design ready for transfer:
As pressure to accelerate grows across medtech, many teams are discovering a paradox: the harder we push for speed, the more we introduce delays, misalignment, and rework. In this webinar, Bryan Gilpin and Terri Kapur explore what’s really getting in the way—and how to build a foundation for true development speed.
An Interview with Mike Magliochetti I’ve known Mike Magliochetti for years. He’s the kind of person who makes you think harder in a conversation than you expected to when you sat down. So, when he told me he had written and published a book, Dancing Between the Toes of Elephants, about his transition from medtech […]
Terri Kapur is a seasoned R&D executive with more than 20 years of experience driving innovation in the medical device industry. She has led global, multidisciplinary teams across the full product lifecycle, from early research through development, commercialization, and post-market support.
From smart devices to systems that learn AI in medtech has moved beyond experimentation. Today, it’s embedded across clinical workflows, driving real impact. But we’re seeing a clear shift in what success looks like next. In this perspective, we explore how the future is no longer about isolated intelligent devices. It’s about connected systems that […]
How workflow, IT integration, and reimbursement gaps stall promising devices—and what to do about it In 2011, when the early AI engine IBM Watson won a three-game exhibition tournament of Jeopardy, besting two human contestants who were widely considered to be the greatest ever to play the game, it was considered a real breakthrough for […]
Healthcare collects more data than any industry on earth. Most of it never gets used. Here’s why that paradox persists, and what has to change. Healthcare data is growing at 36% annually, faster than financial services, faster than media. Yet the majority of what gets collected sits idle, generating cost and complexity without generating insight. […]
The Hippocratic Oath and its famous dictum, “First, do no harm” (primum non nocere), have been part of the medical world for centuries, a telling sign of medicine’s long-standing commitment to prioritizing the welfare of the patient. But what it meant to “first, do no harm” back in the day when care was dictated almost […]
New product development processes that are overly siloed are stifling medtech innovation. Here’s why and the steps you can take to get engineering, clinical, regulatory, marketing, and manufacturing all working in parallel from day one.
